The Obama administration recently finalized new rules that require researchers to make trial data public.
In its first year of operations, IDT Biologika’s contract manufacturing facility in Rockville, Maryland has experienced rapid growth, which it expects to continue as construction carries on.
Crown Bioscience has published an updated version of its XenoBase, an online database collating cell line and cell line derived xenograft model data.
While the demand for new diabetes therapies grows, the development of endocrine drugs is riskier than all other drug development, according to a study conducted by Tufts.
Digital health devices are increasingly being used by the industry to collect patient-generated data in clinical trials – and adoption is expected to continue.